Lumenato™ Receives EFSA Approval, Expanding Market Availability
There’s a lot to look forward to.
Due to successful results in the first phase of our study on the effects of our Lutein Complex on ocular blood flow, we’re set to proceed with phase two of the project.
May 19, 2016
Testing our products to prove clinical efficacy is one of our core values, and something that sets us apart in the industry. Due to successful results in the first phase of our study on the effects of our Lycored Lutein Complex on ocular blood flow, we’re set to proceed with phase two of the project. The results of the study showed that subjects who ingested our blend had significantly reduced systolic and diastolic blood pressures and increased retinal capillary blood flow markers. Professor Alon Harris, principal clinical study investigator, believes that “these initial results of the […] study showcase the importance of the development of supplements for eyes and where the future of the vision health industry is heading.” We hope to keep the promising results coming, and we’re excited to see what phase two brings.
Continue reading
The FDA and HHS formalizes plans to phase out synthetic colors
On April 22nd, the FDA announced in a press release its intention to phase out petroleum-based synthetic dyes in food, beyond Red 3. While industry actors seem to be divided...
Nature based solutions to replace artificial colors
Consumer awareness of food, health, and other household products is growing and with that, the demand for naturally derived, plant-based colors is soaring.
We're here for you
Interested in speaking directly with a member of our team?
Click below to get in touch.